RNS System LGS Feasibility Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 4, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
EpilepsyLennox Gastaut SyndromeLennox-Gastaut Syndrome, IntractableSeizuresSeizures, Generalized
Interventions
DEVICE

RNS System

The RNS System provides closed loop responsive brain stimulation. The Neurostimulator monitors the electrical activity of the brain to detect abnormal activity that could lead to a seizure. If abnormal activity is detected, the neurostimulator delivers electrical stimulation to the brain through the leads to help prevent the seizure before it occurs.

Trial Locations (6)

10016

RECRUITING

NYU Langone Medical Center, New York

10029

RECRUITING

Mount Sinai Hospital, New York

30322

RECRUITING

Emory University, Atlanta

35294

RECRUITING

University of Alabama at Birmingham, Birmingham

94143

RECRUITING

University of California, San Francisco, San Francisco

02114

RECRUITING

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

University of Florida

OTHER

lead

NeuroPace

INDUSTRY

NCT05339126 - RNS System LGS Feasibility Study | Biotech Hunter | Biotech Hunter